| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Etomoxir |
乙莫克舍 |
124083-20-1 |
详细
|
| Ketorolac tromethamine salt |
酮咯酸氨丁三醇 |
74103-07-4 |
详细
|
| SPL-707 |
|
2195361-33-0 |
详细
|
| AS2717638 |
|
2148339-28-8 |
详细
|
| PS10 |
|
1564265-82-2 |
详细
|
| N6-Etheno 2'-deoxyadenosine |
N6-亚乙烯基-2'-脱氧腺苷 |
68498-25-9 |
详细
|
| TH5487 |
TH 5487 |
2304947-71-3 |
详细
|
| NIK SMI1 |
|
1660114-31-7 |
详细
|
| TMP778 |
化合物 T13172L |
1422053-04-0 |
详细
|
| TRPV4 agonist-1 free base |
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
2314467-59-7 |
详细
|
| IHVR-11029 |
3,4,5-Piperidinetriol, 1-[6-(2,5-difluorophenoxy)hexyl]-2-(hydroxymethyl)-, (2R,3R,4R,5S)- |
1383152-30-4 |
详细
|
| c-di-AMP disodium |
环二腺苷酸二钠盐 |
2734909-87-4 |
详细
|
| Patamostat |
4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate |
114568-26-2 |
详细
|
| Manitimus |
202057-76-9 |
202057-76-9 |
详细
|
| BI-671800 |
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 |
1093108-50-9 |
详细
|
| ADU-S100 ammonium salt |
ADU-S100铵盐 |
1638750-96-5 |
详细
|
| RIPA-56 |
|
1956370-21-0 |
详细
|
| ARN 077 |
化合物 T10370 |
1373625-34-3 |
详细
|
| Jedi2 |
|
651005-90-2 |
详细
|
| KAG-308 |
|
1215192-68-9 |
详细
|
| MTI-31 |
|
1567915-38-1 |
详细
|
| Tazanolast |
他扎司特 |
82989-25-1 |
详细
|
| Zaltoprofen |
扎托布洛芬 |
74711-43-6 |
详细
|
| 3'-Azido-3'-deoxy-5-fluorocytidine |
|
2095417-18-6 |
详细
|
| C-178 |
N-(二苯并[B,D]呋喃-3-基)-5-硝基呋喃-2-甲酰胺 |
329198-87-0 |
详细
|
| RGX-104 |
|
610318-54-2 |
详细
|
| HPGDS inhibitor 2 |
GSK-2894631A |
2101626-26-8 |
详细
|
| BAY-218 |
CPD3504 |
2162982-11-6 |
详细
|
| Ibufenac |
异丁芬酸 |
1553-60-2 |
详细
|
| NF-56-EJ40 |
|
2380230-73-7 |
详细
|
| SR-717 |
|
2375421-09-1 |
详细
|
| ATX inhibitor 5 |
|
2402772-45-4 |
详细
|
| LDC7559 |
|
2407782-01-6 |
详细
|
| CU-115 |
化合物CU-115 |
2471982-20-2 |
详细
|
| EMD527040 |
|
851333-14-7 |
详细
|
| ATB-346 |
ATB 346 |
1226895-20-0 |
详细
|
| Albendazole sulfoxide-d3 |
阿苯哒唑亚砜-D3 |
1448346-38-0 |
详细
|
| ZCZ011 |
ZCZ 011 |
1998197-39-9 |
详细
|
| Avelumab |
阿维鲁单抗 |
1537032-82-8 |
详细
|
| CU-CPT-9a |
CU-CPT-9B, CPD2004 |
2165340-32-7 |
详细
|
| PA-9 |
N-[2-(1H-imidazol-5-yl)ethyl]-1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carboxamide |
1436004-46-4 |
详细
|
| PF-06747711 |
化合物 T16495 |
1892576-58-7 |
详细
|
| RU-301 |
|
1110873-99-8 |
详细
|
| Naltriben mesylate |
化合物 T23054 |
122517-78-6 |
详细
|
| Linzagolix |
林扎戈利 |
935283-04-8 |
详细
|
| PI3Kδ-IN-1 |
|
1911564-39-0 |
详细
|
| SPD304 dihydrochloride |
TNF-α inhibitor |
1049741-03-8 |
详细
|
| SOCE inhibitor 1 |
|
2169316-15-6 |
详细
|
| PDE12-IN-3 |
|
1803357-22-3 |
详细
|
| ML604440 |
ML 604440 |
1140517-08-3 |
详细
|
| Roflupram |
1-Butanone, 1-[4-(difluoromethoxy)-3-[(tetrahydro-3-furanyl)oxy]phenyl]-3-methyl- |
1093412-18-0 |
详细
|
| (S)-Coriolic acid |
13(S)-HYDROXYOCTADECA-9Z,11E-DIENOIC ACID |
29623-28-7 |
详细
|
| Eliapixant |
依利哌嗪 |
1948229-21-7 |
详细
|
| AZ2 |
|
2231760-33-9 |
详细
|
| CP 376395 |
|
175140-00-8 |
详细
|
| PKA-IN-1 |
1-ACETAMIDO-4-CYANO-3-METHYLISOQUINOLINE |
179985-52-5 |
详细
|
| SB-747651A dihydrochloride |
SB-747651A二盐酸盐 |
1781882-72-1 |
详细
|
| UCB9608 |
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺 |
1616413-96-7 |
详细
|
| N6-(2-Phenylethyl)adenosine |
N6-PHENETHYLADENOSINE; N6-PHENYLETHYLADENOSINE |
20125-39-7 |
详细
|
| KPLH1130 |
|
906669-07-6 |
详细
|
| (αR,8aS)-GSK1614343 |
化合物 T27451 |
1092476-84-0 |
详细
|
| J-2156 TFA |
化合物 J-2156 TFA |
2387505-73-7 |
详细
|
| Zetomipzomib maleate |
|
2170983-62-5 |
详细
|
| A-770041 |
|
869748-10-7 |
详细
|
| Verucerfont |
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺 |
885220-61-1 |
详细
|
| NOD-IN-1 |
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 |
132819-92-2 |
详细
|
| Icerguastat |
化合物SEPHIN 1 |
951441-04-6 |
详细
|
| Zegocractin |
CS-2907 |
1713240-67-5 |
详细
|
| INF4E |
Benzenepropanoic acid, 2-chloro-b-hydroxy-a-methylene-, ethyl ester |
88039-46-7 |
详细
|
| H-151 |
|
941987-60-6 |
详细
|
| DS-437 |
|
1674364-87-4 |
详细
|
| TH1020 |
|
1841460-82-9 |
详细
|
| JNJ-55308942 |
JNJ-55308942
(JNJ55308942) |
2166558-11-6 |
详细
|
| SPR inhibitor 3 |
N-[2-(5-Hydroxy-2-methyl-1H-indol-3-yl)ethyl]-2-methoxyacetamide |
1292285-54-1 |
详细
|
| MLT-748 |
|
1832578-30-9 |
详细
|
| Labetalol |
拉贝洛尔 |
36894-69-6 |
详细
|
| BMS-470539 dihydrochloride |
BMS 470539 DIHYDROCHLORIDE |
2341796-82-3 |
详细
|
| Ly93 |
|
1883528-69-5 |
详细
|
| Ensifentrine |
恩塞芬汀 |
1884461-72-6 |
详细
|
| Syk-IN-1 |
1,2,4-Triazine-6-carboxamide, 3-[[(1R,2S)-2-aminocyclohexyl]amino]-5-(1H-indol-7-ylamino)- |
1491150-77-6 |
详细
|
| GX-201 |
GX 201 |
1788071-27-1 |
详细
|
| CRAC intermediate 2 |
4-(3,5-双(三氟甲基)-1H-吡唑-1-基)-苯胺 |
123066-64-8 |
详细
|
| Trimethylamine N-oxide-d9 |
N,N-Di(Methyl-d3)Methan-d3-aMine N-Oxide |
1161070-49-0 |
详细
|
| (S)-Flurbiprofen |
(S)-氟比洛芬 |
51543-39-6 |
详细
|
| GSK3179106 |
|
1627856-64-7 |
详细
|
| TLR7 agonist 2 |
CS-2748 |
1642857-69-9 |
详细
|
| Synta66 |
化合物SYNTA66 |
835904-51-3 |
详细
|
| (S)-Ketoprofen |
右旋酮洛芬 |
22161-81-5 |
详细
|
| PAP-1 |
4-(4-苯氧基丁氧基)-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮 |
870653-45-5 |
详细
|
| TC-S 7005 |
|
1082739-92-1 |
详细
|
| diABZI STING agonist-1 trihydrochloride |
|
2138299-34-8 |
详细
|
| GSK 366 |
GSK366) |
1953157-39-5 |
详细
|
| S18-000003 |
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
2068119-11-7 |
详细
|
| UCB-9260 |
|
1515888-53-5 |
详细
|
| CTPI-2 |
2-(4-氯-3-硝基苯基磺酰胺基)苯甲酸 |
68003-38-3 |
详细
|
| Paquinimod |
帕奎莫德 |
248282-01-1 |
详细
|
| UNC0379 |
|
1620401-82-2 |
详细
|
| Triflusal |
三氟醋柳酸 |
322-79-2 |
详细
|
| YQ128 |
化合物YQ128 |
2454246-18-3 |
详细
|
| TAK1-IN-4 |
化合物HS220 |
1570374-32-1 |
详细
|